| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/02/2007 | US7276227 Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity |
| 10/02/2007 | CA2419046C Method for detecting or measuring hbv |
| 10/02/2007 | CA1341552C Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof |
| 09/27/2007 | WO2007109035A2 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 09/27/2007 | WO2007108559A1 Agonistic antibody directed against human thrombopoietin receptor |
| 09/27/2007 | WO2007108464A1 Antibody directed against mammal-derived cytoplasmic sialidase |
| 09/27/2007 | WO2007108205A1 Cell culture substrate |
| 09/27/2007 | WO2007108152A1 High functional bispecific antibody |
| 09/27/2007 | WO2007048030A3 Plants expressing environmental stress tolerances having petunia cbf genes therein |
| 09/27/2007 | WO2007041087A3 Nucleic acids encoding a functional mammalian purinoreceptor, p2x3, methods of production and use thereof |
| 09/27/2007 | WO2007005596A3 Production of cpd glycosylases |
| 09/27/2007 | WO2005046583A3 Modified fviii having reduced immunogenicity through mutagenesis of a2 and c2 epitopes |
| 09/27/2007 | US20070226815 Protein with immunomodulatory activity, antiviral activity, and antitumor activity encoded by a IFN-alpha upregulated gene; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals, primers, probes, antibodies |
| 09/27/2007 | US20070225480 small ubiquitin-like modifier (SUMO); for diagnosis and treatment of Type 1 diabetes |
| 09/27/2007 | US20070225224 Modified Vitamin K-Dependent Polypeptides |
| 09/27/2007 | US20070225223 Modified Vitamin K-Dependent Polypeptides |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070225205 Interferon-alpha polypeptides and conjugates |
| 09/27/2007 | US20070225204 Interferon-alpha polypeptides and conjugates |
| 09/27/2007 | US20070224679 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 09/27/2007 | US20070224665 Using coordinate directed mutation to generate of interest; directed protein evolution |
| 09/27/2007 | US20070224664 System for Antibody Expression and Assembly |
| 09/27/2007 | US20070224663 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods |
| 09/27/2007 | US20070224662 Post-translational modification of proteins in cell-free expression systems |
| 09/27/2007 | US20070224656 Modulation of Abeta levels by beta-secretase BACE2 |
| 09/27/2007 | US20070224649 Novel scavenger receptor |
| 09/27/2007 | US20070224647 Monitor protein for measuring processing of protein |
| 09/27/2007 | US20070224635 Regulated Stop Codon Readthrough |
| 09/27/2007 | US20070224325 Xylanase |
| 09/27/2007 | US20070224211 HIV-1 glycopeptides and derivatives; preparation and applications thereof |
| 09/27/2007 | US20070224201 Maytansinoid conjugated immunoglobulin for use in prevention, detection and treatment of cell proliferative disorders |
| 09/27/2007 | US20070224198 Antithrombotic agents |
| 09/27/2007 | US20070224196 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 09/27/2007 | US20070224193 Methods of increasing lean tissue mass using ob protein compositions |
| 09/27/2007 | US20070224185 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 09/27/2007 | US20070224183 Pure drug product consisting of collagenase I and collagenase II having the sequence of Clostridium histolyticum collagenase I and collagenase II; possibly Xiaflex (tradename) |
| 09/27/2007 | US20070224125 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 09/27/2007 | CA2647380A1 Methods for humanizing antibodies and humanized antibodies made thereby |
| 09/27/2007 | CA2646329A1 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 09/27/2007 | CA2644663A1 Agonist antibody to human thrombopoietin receptor |
| 09/27/2007 | CA2638772A1 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| 09/26/2007 | EP1837400A1 Novel tannase gene and protein thereof |
| 09/26/2007 | EP1837396A1 Salutaridine reductase and morphine biosynthesis |
| 09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 09/26/2007 | EP1836305A1 Expression vectors for treating bacterial infections |
| 09/26/2007 | EP1836298A2 COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| 09/26/2007 | EP1836297A2 Phi 15 dna polymerase |
| 09/26/2007 | EP1836214A2 Compositions, methods, and kits for enhancing protein expression, solubility and isolation |
| 09/26/2007 | EP1835935A2 Compositions and methods for enhanced dendritic cell maturation and function |
| 09/26/2007 | EP1835927A1 Modified beta thymosin peptides |
| 09/26/2007 | EP1610802A4 Parkin interacting polypeptides and methods of use |
| 09/26/2007 | EP1495142B1 "doping" in walk-through mutagenesis |
| 09/26/2007 | EP1490768B1 Adaptive behavioural intrusion detection |
| 09/26/2007 | EP1477566B1 Germ extract for cell-free protein synthesis and process for producing the same |
| 09/26/2007 | EP1391464B1 Anti-cd40 monoclonal antibody |
| 09/26/2007 | EP1194447B1 Novel potassium channels and genes encoding these potassium channels |
| 09/26/2007 | EP1035865B1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/26/2007 | EP0937140B1 Antibody molecules which interact specifically with the active site or cleft of a target molecule |
| 09/26/2007 | EP0787191B1 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 09/26/2007 | CN101044245A Mutant e. coli strain with increased succinic acid production |
| 09/26/2007 | CN101044239A Mammalian cell culture processes for protein production |
| 09/26/2007 | CN101044165A Irta-4 antibodies and their uses |
| 09/26/2007 | CN101044154A Chimeric molecules for cleavage in a treated host |
| 09/26/2007 | CN101041846A Preparation method and usage for novel lipopeptide type biosurfactant surfactin |
| 09/26/2007 | CN101041845A Method for producing chymosin dry casein by using Qula as raw material |
| 09/26/2007 | CN101041842A Clean producing method for chondroitin sulfuric acid and proteins |
| 09/26/2007 | CN101041819A High level expression of human erythropoietin gene in stably transfected mammalian cells. |
| 09/26/2007 | CN101041690A Recombinant dog hookworm coagulate peptide resistant 5 mutant, its encoding gene, preparation and application thereof |
| 09/26/2007 | CN100339482C Hybrid expression of neisserial proteins |
| 09/26/2007 | CN100339475C Colibacillns strain for recombination producing lectin of snowdrop and method thereof |
| 09/26/2007 | CN100339395C E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 09/26/2007 | CN100339389C 丙型肝炎三肽抑制剂 Tripeptide inhibitor of hepatitis C |
| 09/25/2007 | US7273930 Immunization of dairy cattle with GapC protein against Streptococcus infection |
| 09/25/2007 | US7273929 B1k chain of laminin and methods of use |
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273926 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
| 09/25/2007 | US7273925 Methods and products for regulating lectin complement pathway associated complement activation |
| 09/25/2007 | US7273920 Controlling protein levels in eucaryotic organisms |
| 09/25/2007 | US7273754 Core 1 β3-galactosyltransferase specific molecular chaperones, nucleic acids, and methods of use thereof |
| 09/25/2007 | US7273748 Cellulases, the genes encoding them and uses thereof |
| 09/25/2007 | US7273746 Microbial oils enriched in omega fatty acids in oleaginous yeast (e.g., Yarrowia lipolytica) |
| 09/25/2007 | US7273740 Enzymes having alpha amylase activity and methods of use thereof |
| 09/25/2007 | US7273739 Claimed are specific enzymes having strand cleavage activity, 3' to 5' exonuclease activity, and polymerase activity that are combined with a heteroduplex polynucleotide to increased complementarity within the heteroduplex |
| 09/25/2007 | US7273735 Making valencene by contacting farnesyl-pyrophosphate with a valencene synthase that has been encoded by a nucleic acid with a specific sequence, especially from grapefruit |
| 09/25/2007 | US7273729 Chondroitin synthase and DNA encoding the enzyme |
| 09/25/2007 | US7273728 Fermenting an appropriate microorganism using glucose as a carbon source and operating two chromatographic separation steps wherein ion exchange chromatography is followed by hydrophobic interaction chromatography, wherein the diphtheria toxin has a purity of at least 98%. |
| 09/25/2007 | US7273727 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
| 09/25/2007 | US7273726 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 09/25/2007 | US7273725 Human and mammalian stem cell-derived neuron survival factors |
| 09/25/2007 | US7273724 Also producing the polypeptide by DNA recombinant technology |
| 09/25/2007 | US7273722 Insertion of cleavage sites in non-critical regions of the toxins which are susceptible to protease activity in non-target tissues and single chain forms activated by proteases in the target; botulism and tetanus toxins; confine activity to target site; side effect reduction |
| 09/25/2007 | US7273709 Detection of sarcocystis neurona |
| 09/25/2007 | US7273703 Detection of mutations |
| 09/25/2007 | US7273615 Reaction solution for cell-free protein synthesis, method of preparing the same, and protein synthesis method using the same |
| 09/25/2007 | US7273611 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
| 09/25/2007 | CA2237338C Stable avidin composition and methods using same |
| 09/25/2007 | CA2214018C An immortalized mammal hybridoma fusion partner |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/25/2007 | CA2128109C Improvements in or relating to malaria vaccine |